BIIB

Biogen
D

BIIB

Arincen57/100B

Biogen shares outstanding 1985–2026

Biogen had 147,820,000 shares outstanding on 13 November 2026. Biogen had 147.90M diluted shares on average over the last twelve months, up 1.1% on the twelve months before. In fiscal year 2025 the average was 146.70M.

Last updated 9 Nov 2026 · Next report 5 Feb 2027

Shares outstanding

Change on the year

Fiscal yearPeriod endingShares outstandingChange on the yearBasic shares
TTM30 Sept 2026147.90M+1.13%147.35M
FY202531 Dec 2025146.70M+0.55%146.70M
FY202431 Dec 2024145.90M+0.21%145.70M
FY202331 Dec 2023145.60M-0.27%144.70M
FY202231 Dec 2022146.00M-2.41%145.30M
FY202131 Dec 2021149.60M-7.25%149.10M
FY202031 Dec 2020161.30M-13.93%160.90M
FY201931 Dec 2019187.40M-8.72%187.10M
FY201831 Dec 2018205.30M-3.62%204.90M
FY201731 Dec 2017213.00M-2.65%212.60M
FY201631 Dec 2016218.80M-5.36%218.40M
FY201531 Dec 2015231.20M-2.52%230.70M
FY201431 Dec 2014237.18M-0.48%236.36M
FY201331 Dec 2013238.31M-0.60%236.92M
FY201231 Dec 2012239.74M-2.16%237.94M
FY201131 Dec 2011245.03M-3.86%242.40M
FY201031 Dec 2010254.87M-11.96%252.31M
FY200931 Dec 2009289.48M-1.87%287.36M
FY200831 Dec 2008294.98M-7.87%292.33M
FY200731 Dec 2007320.17M-7.27%315.84M
FY200631 Dec 2006345.28M-0.25%338.59M
FY200531 Dec 2005346.16M+0.78%335.59M
FY200431 Dec 2004343.48M+2.93%335.00M
FY200331 Dec 2003333.70M-16.31%333.70M
FY200231 Dec 2002398.75M0.00%389.96M
FY200131 Dec 2001398.75M-14.03%389.96M
FY200031 Dec 2000463.81M-2.02%446.23M
FY199931 Dec 1999473.36M-49.94%449.76M
FY199831 Dec 1998945.52M+2.03%884.52M
FY199731 Dec 1997926.67M+0.41%877.90M
FY199631 Dec 1996922.86M+30.90%850.00M
FY199531 Dec 1995705.00M-13.60%705.00M
FY199431 Dec 1994816.00M+0.74%816.00M
FY199331 Dec 1993810.00M-4.83%747.69M
FY199231 Dec 1992851.11M+26.09%820.71M
FY199131 Dec 1991675.00M+25.00%675.00M
FY199031 Dec 1990540.00M+38.46%540.00M
FY198931 Dec 1989390.00M+62.50%390.00M
FY198831 Dec 1988240.00M-53.98%240.00M
FY198731 Dec 1987521.54M+10.97%521.54M
FY198631 Dec 1986470.00M+6.63%470.00M
FY198531 Dec 1985440.77M—440.77M

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,Net income,EPS,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about Biogen's shares

Source: Financial Modeling Prep